留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

家族性地中海热的神经系统临床表现

董耀华 宋红梅

董耀华, 宋红梅. 家族性地中海热的神经系统临床表现[J]. 协和医学杂志, 2023, 14(2): 334-338. doi: 10.12290/xhyxzz.2022-0093
引用本文: 董耀华, 宋红梅. 家族性地中海热的神经系统临床表现[J]. 协和医学杂志, 2023, 14(2): 334-338. doi: 10.12290/xhyxzz.2022-0093
DONG Yaohua, SONG Hongmei. Neurological Manifestations in Familial Mediterranean Fever[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 334-338. doi: 10.12290/xhyxzz.2022-0093
Citation: DONG Yaohua, SONG Hongmei. Neurological Manifestations in Familial Mediterranean Fever[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 334-338. doi: 10.12290/xhyxzz.2022-0093

家族性地中海热的神经系统临床表现

doi: 10.12290/xhyxzz.2022-0093
基金项目: 

国家重点研发计划 2021YFC2702001

北京市自然科学基金 L202050

详细信息
    通讯作者:

    宋红梅, E-mail:songhm1021@126.com

  • 中图分类号: R593;R596;R741

Neurological Manifestations in Familial Mediterranean Fever

Funds: 

National Key Research and Development Program of China 2021YFC2702001

Beijing Natural Science Foundation L202050

More Information
  • 摘要: 家族性地中海热(familial Mediterranean fever, FMF)是一种由MEFV基因突变导致的自身炎症性疾病, 主要临床表现为反复发作的发热和全身多处浆膜炎症, 部分FMF患者还可出现神经系统临床表现, 如癫痫、脱髓鞘疾病、无菌性脑膜炎等。由于FMF患者的神经系统表现较为罕见, 临床中易忽视其与基因突变的联系。本文针对FMF的重要神经系统表现及其与基因型的关系进行阐述, 以加深对FMF的认识, 为临床诊疗提供借鉴和参考。
    作者贡献:董耀华负责查阅文献资料、撰写论文;宋红梅负责指导论文撰写、提出修改意见。
    利益冲突:所有作者均声明不存在利益冲突
  • [1] Ozen S. Update in familial Mediterranean fever[J]. Curr Opin Rheumatol, 2021, 33: 398-402. doi:  10.1097/BOR.0000000000000821
    [2] Bhatt H, Cascella M. Familial Mediterranean Fever[M]. In StatPearls, StatPearls Publishing, 2022.
    [3] Shinar Y, Ceccherini I, Rowczenio D, et al. ISSAID/EMQN Best practice guidelines for the genetic diagnosis of Monognenic AIDs in the next generaion sequencing era[J]. Clin Chem, 2020, 66: 525-536. doi:  10.1093/clinchem/hvaa024
    [4] Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever[J]. Pediatr Neurol, 1993, 9: 301-302. doi:  10.1016/0887-8994(93)90068-N
    [5] Ertekin V, Selimoglu MA, Pirim I. Familial Mediterranean fever in a childhood population in eastern Turkey[J]. Pediatr Int, 2005, 47: 640-644. doi:  10.1111/j.1442-200x.2005.02140.x
    [6] Canpolat M, Gumus H, Gunduz Z, et al. Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey[J]. Neuropediatrics, 2017, 48: 79-85.
    [7] Canpolat M, Kumandas S, Poyrazoglu HG, et al. Preval-ence and risk factors of epilepsy among school children in Kayseri City Center, an urban area in Central Anatolia, Turkey[J]. Seizure, 2014, 23: 708-716. doi:  10.1016/j.seizure.2014.05.012
    [8] Salehzadeh F, Azami A, Motezarre M, et al. Neurological Manifestations in Familial Mediterranean Fever: a Genotype-Phenotype Correlation Study[J]. Open Access Rheumatol, 2020, 12: 15-19. doi:  10.2147/OARRR.S238649
    [9] World Health Organization. Epilepsy in the WHO Eastern Mediterranean region: bridging the gap[EB/OL].[2022-03-01]. https://apps.who.int/iris/handle/10665/119905.
    [10] Çomak E, Tüfekçi Ö, Kiliçbay F, et al. Febrile seizures in children with familial Mediterranean fever: Coincidence or association?[J]. Eur J Paediatr Neurol, 2015, 19: 572-576. https://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ202117014.htm
    [11] Carman KB, Ekici A, Yimenicioglu S, et al. The preval-ence of febrile seizure and associated factors among Turkish children[J]. Int J Clin Pediatr, 2014, 3: 1-4.
    [12] Okan N, Okan M, Eralp O, et al. The prevalence of neurological disorders among children in Gemlik (Turkey)[J]. Dev Med Child Neurol, 1995, 37: 597-603.
    [13] Yakinci C, Kutlu NO, Durmaz Y, et al. Prevalence of febrile convulsion in 3637 children of primary school age in the province of Malatya[J]. Turk J Trop Pediatr, 2000, 46: 249-250. doi:  10.1093/tropej/46.4.249
    [14] Özen F, Kocak N, Kelekci S, et al. The prevalence of Familial Mediterranean Fever common gene mutations in patients with simple febrile seizures[J]. Eur Rev Med Pharmacol Sci, 2014, 18: 657-660.
    [15] Biro O, Gileles-Hillel A, Dor-Wollman T, et al. Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings[J]. Eur J Pediatr, 2022, 181: 973-978. doi:  10.1007/s00431-021-04286-7
    [16] Akman-Demir G, Gul A, Gurol E, et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?[J] J Neurol, 2006, 253: 928-934. doi:  10.1007/s00415-006-0137-8
    [17] Unal A, Dursun A, Emre U, et al. Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients: is it a susceptibility gene?[J]. J Neurol Sci, 2010, 294: 38-42. doi:  10.1016/j.jns.2010.04.008
    [18] Shinar Y, Livneh A, Villa Y, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients[J]. Genes Immun, 2003, 4: 197-203. doi:  10.1038/sj.gene.6363967
    [19] Kalyoncu U, Eker A, Oguz KK, et al. Familial Mediterranean fever and central nervous system involvement: a case series[J]. Medicine, 2010, 89: 75-84. doi:  10.1097/MD.0b013e3181d5dca7
    [20] Yahalom G, Kivity S, Lidar M, et al. Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world's largest FMF cohorts[J]. Eur J Neurol, 2011, 18: 1146-1150. doi:  10.1111/j.1468-1331.2011.03356.x
    [21] Furlan R, Filippi M, Bergami A, et al. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study[J]. J Neurol Neurosurg Psychiatry, 1999, 67: 785-788. doi:  10.1136/jnnp.67.6.785
    [22] Elhani I, Dumont A, Vergneault H, et al. Association between familial Mediterranean fever and multiple sclerosis: A case series from the JIR cohort and systematic literature review[J]. Mult Scler Relat Disord, 2021, 50: 102834. doi:  10.1016/j.msard.2021.102834
    [23] Karachaliou I, Karachalios G, Charalabopoulos A, et al. Meningitis associated with familial Mediterranean fever[J]. Int J Clin Pract Suppl, 2005, 147: 60-61.
    [24] Schwabe AD, Monroe JB. Meningitis in familial Mediterranean fever[J]. Am J Med, 1988, 85: 715-717. doi:  10.1016/S0002-9343(88)80248-1
    [25] Barakat MH, Mustafa HT, Shakir RA. Mollaret's meningitis. A variant of recurrent hereditary polyserositis, both provoked by metaraminol[J]. Arch Neurol, 1988, 45: 926-927. doi:  10.1001/archneur.1988.00520320128030
    [26] Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF: published and own experience[J]. Best Pract Res Clin Rheumatol, 2012, 26: 119-133.
    [27] 李栋方, 唐文婷, 邱坤银, 等. 一个常染色体显性遗传型地中海热家系的临床及遗传学分析[J]. 中华医学遗传学杂志, 2021, 38: 719-722. doi:  10.3760/cma.j.cn511374-20200318-00175
    [28] Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension[J]. Neurology, 2002, 59: 1492.
    [29] Gökalp HZ, Başkaya MK, Aydin V. Pseudotumor cerebri with familial Mediterranean fever[J]. Clin Neurol Neurosurg, 1992, 94: 261-263. doi:  10.1016/0303-8467(92)90101-8
    [30] Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome[J]. J Neurol, 2017, 264: 1608-1616. doi:  10.1007/s00415-016-8377-8
    [31] Aksoy DY, Arici M, Kiykim AA, et al. Posterior leukoencephalopathy and nephrotic syndrome: just a coincidence?[J]. Am J Med Sci, 2004, 327: 156-159. doi:  10.1097/00000441-200403000-00008
    [32] Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasog-enic edema[J]. AJNR Am J Neuroradiol, 2008, 29: 1043-1049. doi:  10.3174/ajnr.A0929
    [33] Ulaşli AM, Kutlu G, Kocatürk Ö, et al. Posterior reversible encephalopathy during an attack of familial Mediterranean fever[J]. Rheumatol Int, 2012, 32: 1779-1781. doi:  10.1007/s00296-010-1388-3
    [34] Abbara S, Grateau G, Ducharme-Bénard S, et al. Association of Vasculitis and Familial Mediterranean Fever[J]. Front Immunol, 2019, 10: 763. doi:  10.3389/fimmu.2019.00763
    [35] Nussinovitch U, Volovitz B, Nussinovitch M, et al. Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever[J]. Amyloid, 2011, 18: 206-210.
    [36] Lavi E, Maree A, Eisenstein EM, et al. Increased prevalence of attention-deficit hyperactivity disorder symptomato-logy in patients with familial Mediterranean fever[J]. Mod Rheumatol, 2022, 32: 422-426. doi:  10.1093/mr/roab009
    [37] Wilbur K, Makowsky M. Colchicine myotoxicity: case reports and literature review[J]. Pharmacotherapy, 2004, 24: 1784-1792. doi:  10.1592/phco.24.17.1784.52334
    [38] Ben-Chetrit E, Backenroth R. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene[J]. Ann Rheum Dis, 2001, 60: 146-149. doi:  10.1136/ard.60.2.146
  • 加载中
计量
  • 文章访问数:  2221
  • HTML全文浏览量:  43
  • PDF下载量:  50
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-03-01
  • 录用日期:  2022-03-21
  • 网络出版日期:  2022-10-06
  • 刊出日期:  2023-03-30

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!